FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial

NCT06244004 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

125

Enrollment

OTHER

Sponsor class

Conditions

Castration-Sensitive Prostate Carcinoma
Metastatic Prostate Carcinoma
Stage IVB Prostate Cancer AJCC v8

Interventions

DRUG: Antiandrogen Therapy
PROCEDURE: Bone Scan
PROCEDURE: Computed Tomography
DRUG: Cytotoxic Chemotherapy
PROCEDURE: FDG-Positron Emission Tomography
RADIATION: Radiation Therapy

Sponsor

Northwestern University

Collaborators

National Cancer Institute (NCI)